A New Shear-Stress-Based Point-of-Care Technology for Evaluation of the Hemostatic Pattern in Whole Blood.

Foladore, Alessandro; Lattanzio, Simone; Lombardi, Elisabetta; Durante, Cristina; Baryshnikova, Ekaterina; Anguissola, Martina; Rota, Lidia; Ranucci, Marco; Mazzucato, Mario

The currently available point-of-care hemostasis tests are burdened by criticisms concerning the use of different activators and inhibitors and the lack of dynamic flow. These operating conditions may constitute an impediment to the determination of the patient's hemostatic condition. Hence, the diffusion of these tests in clinical practice is still limited to specific scenarios. In this work, we present a new method for analyzing the patient's global hemostasis based on the visualization of the main components of the coagulation process and its computerized quantitative image analysis. The automated "Smart Clot" point-of-care system presents a micro-fluidic chamber in which whole blood flows, without the addition of any activator or inhibitor. In this micro-channel, platelet adhesion, activation and aggregation to the type I collagen-coated surface take place (primary hemostasis), leading to the production of endogenous thrombin on the surface of platelet aggregates and the consequent fibrin mesh and thrombus formation (secondary hemostasis). These observations are verified by inhibiting primary hemostasis with the antiplatelet drugs Indomethacin (−70% on platelet aggregation, −60% on fibrin(ogen) formation) and Tirofiban (complete inhibition of platelet aggregation and fibrin(ogen) formation) and secondary hemostasis with the antithrombin drugs Heparin (−70% on platelet aggregation, −80% on fibrin(ogen) formation) and Lepirudin (−80% on platelet aggregation, −90% on fibrin(ogen) formation). Smart Clot, through a single test, provides quantitative results concerning platelet aggregation and fibrin formation and is suitable for undergoing comparative studies with other coagulation point-of-care devices.

BLOOD coagulation; PLATELET aggregation inhibitors; POINT-of-care testing; FIBRIN; IMAGE analysis; BLOOD platelet aggregation

Biosensors (2079-6374), 2024, Vol 14, Issue 11, p518

2079-6374

Academic Journal

10.3390/bios14110518